Case ReportAnti-CD20 Monoclonal Antibody (Rituximab) for the Treatment of Recurrent Idiopathic Membranous Nephropathy in a Renal Transplant Patient
Under a Creative Commons license
open archive
Keywords
Anti-CD20 monoclonal antibody
kidney transplantation
recurrent membranous nephropathy
Cited by (0)
Copyright © 2006 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.